Tecan stock: 2026 outlook raised after stronger Q3 growth
Published on 11/19/2026 at 01:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance rises after stronger quarter
- Tecan lifted its 2026 sales growth outlook from low single digits to low-to-mid single digits in local currencies.
- The company confirmed its 2028 targets of CHF 1 billion in sales and a 20 percent adjusted EBITDA margin.
- Life Sciences and Partnering both contributed to third-quarter growth.
Tecan raised its full-year 2026 outlook after third-quarter sales growth accelerated to 6.9 percent in local currencies. In its November 5 announcement, the Swiss laboratory automation group also reported 3.1 percent growth in order entry.
Higher targets for 2026
Tecan now expects sales growth in local currencies in the low-to-mid-single-digit range, compared with its previous low-single-digit forecast. The adjusted EBITDA margin target was raised to 16.5 to 16.8 percent from 15.5 to 16.5 percent.
Life Sciences sales increased 5.6 percent in local currencies, driven by biopharma customers. Partnering Business sales rose 7.8 percent, supported by in-vitro diagnostics systems in the Synergence product line and Paramit CDMO manufacturing services.
Exceptional tariff refunds affect earnings
Tecan said it received CHF 6 million in tariff refunds during the second half of 2026. The refunds will be included in reported EBIT, EBITDA, net earnings and EPS, but excluded from adjusted earnings and the adjusted EBITDA margin outlook because they are exceptional items.
Business and market position
Tecan develops laboratory automation systems and manufactures OEM instruments, components and medical devices for customers ranging from life science research to clinical healthcare. The company is headquartered in Switzerland, has more than 3,000 employees and operates manufacturing and research sites in Europe, North America and Asia. Its sales and service network covers more than 70 countries. Tecan is focused on laboratory automation and OEM healthcare technology rather than a broad diversified industrial portfolio.
Tecan company details
- Company: Tecan Group AG
- ISIN: CH0012100191
- Ticker: TECN
- Home exchange: SIX Swiss Exchange
- Headquarters: Switzerland
The Swiss market environment can be followed through the SMI market overview.
More news and analyses on Tecan stock are available here.
